UK NICE recommends Janssen ’s Ustekinumab treatment for Crohn’s disease

The UK ’s National Institute for Health and Care Excellence (NICE) has recommended Janssen’s Ustekinumab for the treatment of patients with moderate-to-severe Crohn’s disease.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news